Search Results for keywords:"Foreign-Trade Zones Board"

The Foreign-Trade Zones Board has approved the establishment of a subzone at the facilities of Port Arthur LNG, LLC, located in Port Arthur and Jefferson County, Texas. This decision was made after the Board reviewed an application from the Foreign-Trade Zone of Southeast Texas, Inc., and ensured all requirements were met according to U.S. regulations. The subzone status allows the area to be recognized as part of a foreign-trade zone, which is intended to facilitate foreign commerce. The approval is documented and subject to conditions set by the FTZ Act and associated regulations.

Juno Therapeutics, Inc. has submitted a proposal to the Foreign-Trade Zones Board for production activity at its facility in Bothell, Washington. The facility will focus on producing cell therapy products, and the proposal includes plans to utilize foreign-sourced human T-cells, which are duty-free. If approved, this setup could allow Juno to avoid customs duties on certain materials and potentially defer or reduce them on production equipment. Public comments on this proposal are invited until April 12, 2021.

Zinus USA Inc. submitted a notification to the Foreign-Trade Zones Board about their plan for production activity in McDonough, Georgia, within Foreign-Trade Zone 26. The board published this in the Federal Register to invite public comments and later decided that no additional review was necessary. As of February 19, 2021, the production activity was authorized according to the relevant laws and regulations.

Piramal Pharma Solutions has notified the Foreign-Trade Zones Board about proposed production activities at their facility in Philadelphia, within FTZ 35. They plan to produce bempedoic acid tablets and bempedoic oral suspension. The public is encouraged to submit comments on this proposal by March 31, 2025. More details are available on the Board's website, and interested parties can contact Kolade Osho for further information.

Merck, Sharp & Dohme LLC has informed the Foreign-Trade Zones (FTZ) Board about proposed production activities at their Rahway, New Jersey, facility, which is part of Subzone 49Y. The proposal includes producing drugs for metabolic and immunological disorders using specific foreign-sourced materials. Interested parties can submit their comments to the FTZ Board by February 24, 2025. More details and the notification can be accessed on the Board's website.

The Foreign-Trade Zones (FTZ) Board has approved an application to establish Subzone 102G for True Manufacturing Co., Inc., in O'Fallon and Mexico, Missouri. This decision was made on January 7, 2025, following the submission of an application by the St. Louis County Port Authority, which is the grantee of FTZ 102. The application was reviewed and found to meet the necessary criteria, and the new subzone will be subject to FTZ 102's 2,000-acre activation limit. The application process included a public comment period announced in the Federal Register on November 26, 2024.

The Foreign-Trade Zones (FTZ) Board approved an application to expand Subzone 22F in Itasca, Illinois, on behalf of Abbott Laboratories. This decision was made after reviewing the application submitted by the Illinois International Port District, which was processed according to the FTZ Act and Regulations. Public comments were invited through a notice in the Federal Register. The approval is subject to existing regulations, including FTZ 22's 2,000-acre activation limit.

The Erie-Western Pennsylvania Port Authority has submitted an application to the Foreign-Trade Zones Board to designate a Cummins Inc. facility in Irvine, Pennsylvania, as a special subzone. This proposed subzone, spanning 5.87 acres at 200 Murray Drive, would not be authorized for production activities and would adhere to existing limits. Public comments are welcome and must be submitted by February 10, 2025, with follow-up rebuttals due by February 24, 2025. Any inquiries can be directed to Juanita Chen via email, and the application can be reviewed online.

The Foreign-Trade Zones Board authorized a production activity for Renaissance Lakewood, LLC in Lakewood, New Jersey, located in Foreign-Trade Zone 235. This decision came after the Township of Lakewood submitted a proposal on September 30, 2024, which followed all regulatory requirements, including public comment solicitation. On January 28, 2025, it was confirmed that no further review was necessary, and the planned activities were approved under applicable laws and regulations.

Boehringer Ingelheim Animal Health Puerto Rico LLC submitted a notification for proposed production at their facility in Barceloneta, Puerto Rico, within Subzone 61AC. The notification was reviewed by the Foreign-Trade Zones Board, which published an invitation for public comment in the Federal Register on August 14, 2024. On December 6, 2024, the Board decided that no further review was needed and authorized the production activity as described, following their regulations. The decision is noted in Federal Register document number 2024-29086.